Mechanistically, BCR loss impaired mTOR-dependent anabolic control, reducing protein synthesis, while diminished Cyclin D3 abundance sensitized tumor cells to pharmacological CDK4/6 blockade. This evidence concerns the gene BCR and neoplasm.